GlassScriptPhysician profile
Damon R Salzman
NPI 1184672701
$1,520.79
in general payments reported to CMS, 2019-2025
21 companies · $560 in 2025
The $560 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.81 · 2020: $24.22 · 2021: $69.92 · 2022: $131 · 2023: $362 · 2024: $297 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.84 | 2022-2025 | Botox |
| Merz Pharmaceuticals, LLC | $173.86 | 2022-2025 | Xeomin, Inbrija, Ampyra |
| Eisai INC. | $127.82 | 2023-2025 | |
| Janssen Biotech, INC. | $89.94 | 2025 | |
| Lilly USA, LLC | $77.42 | 2023-2025 | Amyvid, Zepbound, Emgality |
| Novartis Pharmaceuticals Corporation | $68.81 | 2019-2020 | |
| Ucb, INC. | $66.50 | 2025 | Rystiggo |
| Genentech USA, INC. | $66.08 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $61.82 | 2023-2025 | Lumryz |
| Argenx US, INC. | $58.90 | 2025 | Vyvgart Hytrulo |
| Lundbeck LLC | $57.21 | 2021-2025 | Vyepti |
| Catalyst Pharmaceuticals, INC. | $53.09 | 2025 | |
| Pfizer INC. | $46.01 | 2023-2025 | |
| Inspire Medical Systems, INC. | $43.52 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $35.29 | 2024-2025 | Austedo Xr, Austedo Xr |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $32.22 | 2019 | |
| Amgen INC. | $25.46 | 2021 | |
| Tg Therapeutics, INC. | $24.25 | 2023 | |
| Boston Scientific Corporation | $21.41 | 2022 | |
| Tms Neurohealth Centers INC. | $17.53 | 2025 | Tms Neurohealth Centers INC. |
| Acadia Pharmaceuticals INC | $15.81 | 2023 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damon Salzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.